Regulatory Story
Go to market news section View chart   Print
RNS
Xaar PLC  -  XAR   

2017 Interim Results

Released 14:43 06-Sep-2017

RNS Number : 0165Q
Xaar PLC
06 September 2017
 

 

 

                  

6 September 2017

AMENDMENT TO THE 2017 INTERIM RESULTS

 

The following amendment has been made to the '2017 Interim Results' announcement released on 06/09/2017 at 07:00 under RNS No 9019P.

 

In the notes to the Condensed Consolidated Financial Information, the corrected text to note 3 is:

 

Assets in the 'product sales, commissions and fees' segment have increased by £13,135,000 over the period and assets in the 'royalties' segment have increased by £184,000 over the period;

The original text was:

 

Assets in the 'product sales, commissions and fees' segment have decreased by £13,135,000 over the period and assets in the 'royalties' segment have decreased by £184,000 over the period;

All other details remain unchanged.

 

The full amended text is shown below.

 

 

Xaar plc

 

 

Interim results in-line with expectations; transforming the business towards 2020 vision

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the inkjet printing technology Group headquartered in Cambridge, UK, today issues its interim report for the six months ended 30 June 2017.

 

 

Adjusted¹


IFRS


H1 2017

H1 2016

H2 2016


H1 2017

H1 2016

H2 2016

Revenue

£44.0m

£44.5m

£51.7m


£44.0m

£44.5m

£51.7m

Gross profit

£20.7m

£19.9m

£24.8m


£20.7m

£19.9m

£24.8m

Gross margin %

47%

45%

48%


47%

45%

48%

Gross R&D investment

£9.7m

£11.2m

£11.2m


£9.7m

£11.2m

£11.2m

Net R&D investment2

£5.0m

£6.3m

£5.9m


£5.0m

£6.3m

£5.9m

Operating margin %

18%

19%

20%


13%

17%

19%

Profit before tax

£7.9m

£8.8m

£10.7m


£5.7m

£7.7m

£10.2m

Diluted earnings per share

9.1p

10.0p

11.2p


5.9p

8.5p

10.4p

Net cash3 at period end

£38.3m

£69.0m

£49.3m


£38.3m

£69.0m

£49.3m

Dividend per share

3.4p

3.3p

6.7p


3.4p

3.3p

6.7p

 

1 Excluding the impact of share-based payment charges, exchange differences relating to intra-group transactions, research and development expenditure credits and restructuring costs

2 Net R&D investment excludes the capitalised costs of the Thin Film (P4) development programme, as required under International Financial Reporting Standards (IAS 38)

3 Net cash includes cash, cash equivalents and treasury deposits

 

Financial highlights

·      Revenue in the first half of the year was in line with the Board's expectations at £44.0 million

·      Revenue excluding licensee royalty grew by 5%. Product revenue outside of Ceramics grew by 60%. The revenue from Engineered Printing Solutions (EPS) for the first half of the year was £6.5 million

·      Profitability consistent with the first half of 2016; gross margin of 47% (H1 2016: 45%); product gross margin was 43% (H1 2016: 36%); and adjusted operating profit margin of 18% (H1 2016: 19%)

·      Net cash at 30 June 2017 of £38.3 million (31 December 2016: £49.3 million), after investment in Thin Film Platform and working capital

·      Interim dividend up 3% to 3.4 pence per share (2016: 3.3 pence per share)

 

Operational & strategic highlights

·      Announcement of the Joint Development Agreement with Xerox to develop the next generation of Industrial Bulk piezo printheads using the extensive combined resources and IP of both companies. The efficiency gains from this agreement will allow Xaar to redeploy resources to strengthen the go-to-market functions to transform the business to become more customer-centric

·      First printhead arising from Xerox collaboration, the Xaar 5501 printhead, generates its first revenues

·      Good progress achieved in launching the new Thin Film printhead 1201, with a master distribution agreement signed for two years for +90,000 printheads

·      5601 design frozen, first development kits shipped, capitalisation stopped at the end of July

·      Establishing European distribution channel for EPS digital product portfolio

 

Doug Edwards, CEO, commented:

 

"We are making good progress in transforming Xaar to a more diversified and customer-centric company. I am particularly pleased with the new product revenue streams we are delivering in Product Printing & Packaging, Graphic Arts, 3D and Advanced Manufacturing. Product revenue in the first half, outside of Ceramics, has grown by 60%. This transformation is not easy so I would like to thank all of our staff for their continued hard work and dedication as we continue to lay the foundations to deliver our 2020 vision."     

 



 


Doug Edwards, Chief Executive Officer

Today: +44 (0) 20-7353-4200

Lily Liu, Chief Financial Officer

Thereafter: +44 (0) 1223-423663

www.xaar.com


James Macey White

+44 (0) 20-7353-4200



 



 

CHAIRMAN'S STATEMENT

 

Introduction

 

During the first half of 2017 we continued our transformation to a more customer-focused and market-led business, whilst delivering financial results in line with expectations. We reviewed and confirmed our strategic vision to grow annual sales to £220 million by 2020, and announced a partnership with Xerox to jointly develop the next generation Bulk piezo platform.

 

Dividend

In 2014 we announced a sustainable and progressive dividend policy which takes into account the Group's future prospects, its underlying profitability and the future cash requirements of the business. 

 

The Board has declared a 2017 interim dividend of 3.4 pence, a 3% increase over the 2016 interim dividend, which will be paid on 12 October 2017, with an ex-dividend date of 14 September 2017 to shareholders on the register at close of business on 15 September 2017.

 

Board

There were two changes to the Board in the first half of the year.

 

On 2 May 2017 Lily Liu joined the Board as Chief Financial Officer. Lily joined us from the Smiths Group plc, where she held a number of senior financial and management roles. Mostly recently, from 2014 to 2016, Lily was CFO of the Smiths Detection Division.

 

On 8 August 2017 it was announced that Ted Wiggans, Chief Operations Officer, plans to retire from the Group on 9 August 2018.

 

Our financial results for the first half of 2017 were in line with expectations and we remain focused on delivering our 2020 vision. I want to thank all our employees for their hard work and commitment.

 

 

 

Robin Williams

Chairman

6 September 2017

 



 

CHIEF EXECUTIVE OFFICER'S STATEMENT

 

Introduction

 

I am pleased with our progress towards the 2020 vision during the first half of the year. Working together with our manufacturing partner for the Thin Film Xaar 5601, the 5601 design has been frozen, and the first development kits shipped. We launched a new Premier Partnership Programme into the Ceramics market to leverage our advanced High Laydown Technology and diversified product portfolio. We continued with our transformation from an internally-focused organisation to a market and customer-centric business; the savings arising from increased efficiency in operations and R&D will be redeployed into our go-to-market functions.

 

Results and business commentary

Revenue for the six months ended 30 June 2017 was £44.0 million (H1 2016: £44.5 million; H2 2016: £51.7 million). 

Revenue excluding licensee royalties was £40.5 million (H1 2016: £38.4 million; H2 2016: £44.5 million). The revenue contribution from the EPS business was £6.5 million for the first half of 2017, consistent with expectations; revenue from the EPS business has been reported within the Packaging and Product Printing market sector.

 

Analysing the geographic split of our revenue based on the location of our customers (and not necessarily end users), Asia has increased to 47% (H1 2016: 42%, H2 2016: 35%), EMEA reduced to 32% (H1 2016: 51%, H2 2016: 36%) and the Americas increased, relative to the same period in 2016, to 21% (H1 2016: 7%, H2 2016: 29%).

 

Sales into Graphic Arts in the first half of 2017 were 33% higher than the same period for 2016, with first set of revenues from the new Thin Film printhead realised at £2m. A master distribution agreement was signed for +90,000 printheads over 2 years.

 

Revenue from Packaging and Product Printing increased by 54% compared to the first six months of 2016; excluding the contribution from the newly acquired EPS business, the revenue from this market declined by 20%. Sub-segments Direct-to-Shape, and Labels provided growth whilst Packaging, and Coding & Marking declined due to the time for the replacement new products to ramp up.

 

Revenue from the Industrial sector declined by 14% compared to the same period in 2016 due to the performance of the Ceramics business (a 25% decline), partially offset by strong growth in all other Industrial sub-segments. As previously reported, the Ceramics sub-segment has reached maturity with nearly all production capacity now converted to digital technology. Progress within Ceramics includes gaining traction within the replacement market with the Xaar 1003 and the launch of the Premier Partnership Programme. This provides access to new advanced technology and products for our Premier Partners. We have established a position in the Textiles sub-segment with the sales of 5601 development kits and the introduction of the 5501. The 3D and Advanced Manufacturing sub-segments continue to grow and are up 200% against H1 2016, with growth in Advanced Manufacturing being driven by demand for flat panel displays.

 

Profitability in the first half of 2017 was consistent with the first six months of 2016; gross margin was 47% (H1 2016: 45%, H2 2016: 48%); product gross margin was 43% (H1 2016: 36%, H2 2016: 40%) due to a favourable product mix effect. Adjusted operating margin was 18% (H1 2016: 19%, H2 2016: 20%).

 

We continue to invest a substantial amount in research and development to deliver our long term strategy, with expenditure before the capitalisation of development costs at 22% of revenue in H1 2017 (H1 2016: 25%). Gross expenditure (before capitalisation) of R&D was £9.7 million in H1 2017 (H1 2016: £11.2 million). Development expenditure on the Thin Film programme (also known as P4) of £4.7 million was capitalised in H1 2017 (H1 2016: £4.9 million), as required under International Financial Reporting Standards (specifically IAS 38). Amortisation of these costs commenced in August following the successful life testing of the printhead and completion of capitalisation at the end of July. Total costs capitalised to June 2017 (from January 2014) were £30.6 million.

 

Adjusted profit before tax for the period was £7.9 million (H1 2016: £8.8 million). The underlying adjusted profit before tax grew by 90%, adjusting for the effect of foreign exchange movements, the one-off benefit from the licensee royalty payment in H1 2016 and the contribution from the EPS business.

 

EPS continued to perform as expected, introducing Roto-JET, its new product, in July 2017 with extensive interest received from end user customers.  

 

At 30 June 2017, Xaar's net cash position was £38.3 million (31 December 2016: £49.3 million), reflecting an employment of working capital to support our new channels and product launches.

 

Strategic Development

We deepened our partnership with Xerox, and launched the new 5501 printhead. This will initially be targeted at the Textiles market and generated its first revenues in H1. In June we announced a Joint Development Agreement with Xerox to develop the next generation of industrial Bulk piezo printheads using the extensive combined resources and IP of both companies. The efficiency gains from this agreement will allow Xaar to redeploy resources to strengthen the go-to-market functions and transform the business to become more customer-centric. 

 

The partnership with Ricoh continues to be strong, with good steps achieved on the 1201 printhead. We have signed a master distribution agreement for the 1201 worth in excess of 90,000 units over 2 years.

 

We continue to make good progress in 3D, having officially opened our Nottingham and Copenhagen centres in H1 and we are developing key strategic OEM partnerships.

 

We are continuing to grow the EPS business and are establishing a European distribution channel for its digital product portfolio.

 

Brexit

Brexit provides a number of challenges for Xaar. The greatest challenge continues to be the likely prolonged period of uncertainty concerning EU workers and migration; one in seven of our current workforce has migrated from the EU and the continued recruitment of world-class talent is critical to our success in a technical and specialised industry. Another challenge for us continues to be free trade into the EU; around one third of our sales are to customers located in EU countries and so any actual or perceived barriers to free trade are an obvious area of concern for us. Brexit continues to be an integral part of the Company's ongoing risk management and review process.

 

Outlook

We have set out our vision to grow annual sales to £220 million by 2020 supported under four strategic pillars: Ceramics, Packaging and Product Printing, Thin Film, and Partnerships and Acquisitions. In the shorter term, despite challenges and low visibility in the Ceramics sector, we are pleased with product revenue growth of 60% outside of Ceramics in the first half and anticipate continued new product growth in the second half of the year.

 

 

Doug Edwards

Chief Executive Officer

6 September 2017

 

 



 

DIRECTORS' RESPONSIBILITIES STATEMENT

We confirm that to the best of our knowledge:

(a)   the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the EU and gives a true and fair view of the assets, liabilities, financial position and profit of the Group.

(b)   the interim management report includes a fair review of the information required by DTR 4.2.7R:

(i)            an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and

(ii)           a description of principal risks and uncertainties for the remaining six months of the year.

(c)   the interim management report includes a fair review of the information required by DTR 4.2.8R:

(i)            related parties transactions that have taken place in the first six months of the current financial year that have materially affected the financial position or performance of the Group in that period, and

(ii)           any changes in the related parties transactions described in the Annual Report 2016 that could have a material effect on the financial position or performance of the Group in the current period.

 

By order of the Board

 

 

 

 

6 September 2017

 

 

 

 



 

CONDENSED CONSOLIDATED INCOME STATEMENT

 

 

FOR THE SIX MONTHS ENDED 30 JUNE 2017

 

 

 

 

Six months ended

Six months ended

Twelve months ended

 

 

30 June 2017

30 June 2016

31 December 2016

 

 

(unaudited)

(unaudited)

(audited)

 

Notes

£'000

£'000

£'000

 

 

 

 

 

Revenue

3

43,953

44,516

96,178

Cost of sales

 

(23,252)

(24,617)

(51,511)

Gross profit

 

20,701

19,899

44,667

Research and development expenses

 

(4,986)

(6,268)

(12,211)

Research and development expenditure credit

 

492

326

605

Sales and marketing expenses

 

(4,022)

(3,166)

(7,608)

General and administration expenses

 

(6,063)

(2,834)

(6,844)

Restructuring costs

 

(588)

(582)

(1,205)

Operating profit

 

5,534

7,375

17,404

Investment income

 

118

281

449

Profit before tax

 

5,652

7,656

17,853

Tax

4

(1,033)

(1,035)

(3,052)

Profit for the period attributable to shareholders

 

4,619

6,621

14,801

Earnings per share

 

 

 

 

Basic

5

6.0p

8.7p

19.4p

Diluted

5

5.9p

8.5p

18.9p

 

Dividends paid in the period amounted to £5,132,000 or 6.7 pence per share 2016 final dividend (six months to 30 June 2016: £4,808,000 or 6.3 pence per share 2015 final dividend; twelve months to 31 December 2016: £7,328,000 or 9.6 pence per share being 6.3 pence per share 2015 final dividend and 3.3 pence per share 2016 interim dividend).

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 JUNE 2017

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Profit for the period attributable to shareholders

4,619

6,621

14,801

Exchange differences on translation of net investment

(160)

284

708

Tax benefit on share option and restructuring gains

-

-

434

Other comprehensive income for the period

(160)

284

1,142

Total comprehensive income for the period

4,459

6,905

15,943

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2017

 

As at

As at

 

30 June 2017

31 December 2016

 

(unaudited)

(audited)

 

£'000

£'000

Non-current assets

 

 

Goodwill

5,776

5,776

Other intangible assets

31,841

27,363

Property, plant and equipment

34,629

36,352

Receivables

1,248

1,516

 

73,494

71,007

Current assets

 

 

Investments

-

1,000

Inventories

19,849

13,790

Trade and other receivables

21,797

20,340

Current tax asset

6,345

3,029

Cash and cash equivalents

38,327

49,321

 

86,318

87,480

Total assets

159,812

158,487

Current liabilities

 

 

Trade and other payables

(13,605)

(14,314)

Other financial liabilities

(74)

(69)

Provisions

(803)

(774)

 

(14,482)

(15,157)

Net current assets

71,836

72,323

Non-current liabilities

 

 

Deferred tax liabilities

(3,574)

(2,686)

Other financial liabilities

(192)

(188)

Total non-current liabilities

(3,766)

(2,874)

Total liabilities

(18,248)

(18,031)

Net assets

141,564

140,456

Equity

 

 

Share capital

7,792

7,778

Share premium

28,027

27,854

Own shares

(3,642)

(3,642)

Other reserves

13,516

11,891

Translation reserve

647

807

Retained earnings

95,224

95,768

Equity attributable to shareholders

141,564

140,456

Total equity

141,564

140,456

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 

FOR THE SIX MONTHS ENDED 30 JUNE 2017

 

 

 

 

 

Share

Share

Own

Other

Translation

Retained

 

 

capital

premium

shares

reserves

reserves

earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balances at 1 January 2017

7,778

27,854

(3,642)

11,891

807

95,768

140,456

Profit for the period

-

-

-

-

-

4,619

4,619

Exchange differences on retranslation of net investment

-

-

-

-

(160)

-

(160)

Total comprehensive income for the period

-

-

-

-

(160)

4,619

4,459

Issue of share capital

14

173

-

-

-

-

187

Dividends (note 6)

-

-

-

-

-

(5,132)

(5,132)

Tax on share options

-

-

-

-

-

(31)

(31)

Credit to equity for equity-settled share-based payments

-

-

-

1,625

-

-

1,625

Balance at 30 June 2017

7,792

28,027

(3,642)

13,516

647

95,224

141,564

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share

Share

Own

Other

Translation

Retained

 

 

capital

premium

shares

reserves

reserves

earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balances at 1 January 2016

7,764

27,585

(3,796)

11,006

99

87,880

130,538

Profit for the period

-

-

-

-

-

6,621

6,621

Exchange differences on retranslation of net investment

-

-

-

-

284

-

284

Total comprehensive income for the period

-

-

-

-

284

6,621

6,905

Issue of share capital

11

207

-

-

-

(2)

216

Own shares sold in the period

-

-

154

-

-

(17)

137

Dividends (note 6)

-

-

-

-

-

(4,808)

(4,808)

Tax on share options

-

-

-

-

-

274

274

Credit to equity for equity-settled share-based payments

-

-

-

654

-

-

654

Balance at 30 June 2016

7,775

27,792

(3,642)

11,660

383

89,948

133,916

 

 

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

FOR THE SIX MONTHS ENDED 30 JUNE 2017

 

 

 

Six months ended

Six months ended

Twelve months ended

 

 

30 June 2017

30 June 2016

31 December 2016

 

 

(unaudited)

(unaudited)

(audited)

 

Note

£'000

£'000

£'000

Net cash from operating activities

8

(245)

12,134

13,935

Investing activities

 

 

 

 

Investment income

 

91

270

471

Acquisition of subsidiary, net of cash acquired

 

-

-

(7,556)

Purchases of property, plant and equipment

 

(2,148)

(5,065)

(10,831)

Proceeds on disposal of property, plant and equipment

 

-

12

16

Redemption of investment

 

1,000

-

-

Expenditure on software

 

(18)

(2)

(85)

Expenditure on capitalised product development

 

(4,655)

(4,902)

(10,222)

Net cash used in investing activities

 

(5,730)

(9,687)

(28,207)

Financing activities

 

 

 

 

Dividends paid

6

(5,132)

(4,808)

(7,328)

Movement in treasury deposits

 

-

6,948

27,098

Proceeds from the sale of ordinary share capital

 

-

137

137

Proceeds from issue of ordinary share capital

 

187

216

282

Net cash (used in)/from financing activities

 

(4,945)

2,493

20,189

Net (decrease)/increase in cash and cash equivalents

 

(10,920)

4,940

5,917

Effect of foreign exchange rate changes

 

(74)

1,248

755

Cash and cash equivalents at beginning of period

 

49,321

42,649

42,649

Cash and cash equivalents at end of period

 

38,327

48,837

49,321

 

Cash and cash equivalents (which are presented as a single class of asset on the face of the condensed consolidated statement of financial position) comprise cash at bank and other short term highly liquid investments with a maturity of three months or less. The carrying amount of these assets is approximately equal to their fair value.

 

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL INFORMATION

 

FOR THE SIX MONTHS ENDED 30 JUNE 2017

 

1. Basis of preparation and accounting policies

Basis of preparation

These interim financial statements have been prepared in accordance with the accounting policies set out in the Group's Annual Report and Financial Statements 2016 on pages 81 to 87 and were approved by the Board of Directors on 6 September 2017. The interim financial statements for the six months ended 30 June 2017 have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the European Union. The interim financial statements do not include all the information and disclosures in the annual financial statements and should be read in conjunction with the Group's annual financial statements as at 31 December 2016.

The financial information in these interim financial statements for the six months ended 30 June 2017, does not constitute statutory financial statements as defined in section 434 of the Companies Act 2006. The Group's Annual Report for the year ended 31 December 2016 has been delivered to the Registrar of Companies and the auditor's report on those financial statements was not qualified and did not contain statements made under section 498(2) or (3) of the Companies Act 2006.

The interim financial statements are unaudited but have been reviewed by the auditor Deloitte LLP. The report of the auditor to the Group is set out at the end of this announcement.

Significant accounting policies

The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 December 2016.

Risks and uncertainties

An outline of the key risks and uncertainties faced by the Group is detailed on pages 23 to 25 of the Xaar plc Annual Report and Financial Statements 2016 (available at www.xaar.com). It is anticipated that the risk profile will not significantly change for the remainder of the year. Risk is an inherent part of doing business and the strong cash position of the Group along with the underlying profitability of the core business leads the Directors to believe that the Group is well placed to manage business risks successfully.

Going concern

The Group's forecasts and projections, taking account of reasonably possible changes in trading performance, support the conclusion that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future, a period not less than 12 months from the date of this report. Accordingly, the going concern basis of preparation has been adopted in preparing the interim financial statements.

 

2. Reconciliation of adjusted financial measures

 

Six months ended

Six months ended

Twelve months ended


30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Profit before tax

                   5,652

             7,656

                17,853

Share-based payment charges

                   1,801

                 692

                      969

Exchange differences relating to intra-group transactions

                       323

                 199

                        60

Restructuring costs

                       588

                 582

                  1,205

Research and development expenditure credit

                     (492)

               (326)

                    (605)

Adjusted profit before tax

                   7,872

             8,803

                19,482

Capitalised research and development expense

(4,697)

(4,902)

(10,222)

Adjusted profit before tax excluding the impact of IAS 38

3,175

3,901

9,260

 

Share-based payment charges include the IFRS 2 charge for the period of £1,625,000 (H1 2016: £654,000) and the charge relating to National Insurance on the outstanding potential share option gains of £176,000 (H1 2016: £38,000). These costs were included in the general and administrative expenses in the Consolidated income statement.

 

Exchange differences relating to the United States and Swedish operations represent exchange gains or losses recorded in the consolidated income statement as a result of operating in the United States and Sweden. These costs were included in general and administrative expenses in the Consolidated income statement.

 

Restructuring costs of £588,000 in H1 2017 (H1 2016: £582,000) relate to costs incurred and provisions made in relation to a reorganisation and the closure of the manufacturing facility in Sweden in 2016.

 

The research and development expenditure credit relates to the corporation tax relief receivable relating to qualifying research and development expenditure. This item is shown on the face of the income statement.

 

Adjusted profit before tax excluding the impact of IAS 38 (capitalisation of development costs) is the measure that is used internally for setting and comparing achievement of the annual bonus target.

 

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

Pence per share

Pence per share

Pence per share

Diluted earnings per share

5.9p

8.5p

18.9p

Share-based payment charges

2.3p

0.9p

1.2p

Exchange differences relating to the intra-group transactions

0.4p

0.3p

0.2p

Restructuring costs

0.8p

0.7p

1.5p

Tax effect of adjusting items

(0.3p)

(0.4p)

(0.6p)

Adjusted diluted earnings per share

9.1p

10.0p

21.2p

 

This reconciliation is provided to enable a better understanding of the Group's results.

 

3. Business segments

For management reporting purposes, the Group's operations are currently analysed according to the two operating segments of 'product sales, commissions and fees' and 'royalties'. These two operating segments are the basis on which the Group reports its primary segment information and on which decisions are made by the Group's Chief Executive Officer and Board of Directors, and resources allocated. The Group's chief operating decision maker is the Chief Executive Officer.

Segment information is presented below:

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Revenue

 

 

 

Product sales, commissions and fees

40,461

38,358

82,863

Royalties

3,492

6,158

13,315

Total revenue

43,953

44,516

96,178

Result

 

 

 

Product sales, commissions and fees

3,843

1,909

5,058

Royalties

3,492

6,158

13,315

Total segment result

7,335

8,067

18,373

Net unallocated corporate expense

(1,801)

(692)

(969)

Operating profit

5,534

7,375

17,404

Investment income

118

281

449

Profit before tax

5,652

7,656

17,853

Tax

(1,033)

(1,035)

(3,052)

Profit for the period attributable to shareholders

4,619

6,621

14,801

 

Unallocated corporate expense relates to administrative activities which cannot be directly attributed to any of the principal product groups, consisting of share-based payment charges.

Assets in the 'product sales, commissions and fees' segment have increased by £13,135,000 over the period and assets in the 'royalties' segment have increased by £184,000 over the period; there have been no other material movements in segment assets during the period.

 

4. Income tax

The major components of income tax expense in the income statement are as follows:

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Current income tax

 

 

 

Income tax charge

205

514

1,730

Deferred income tax

 

 

 

Relating to origination and reversal of temporary differences

828

521

1,322

Income tax expense

1,033

1,035

3,052

 

 

5. Earnings per ordinary share - basic and diluted

The calculation of basic and diluted earnings per share is based upon the following data:

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Earnings

 

 

 

Earnings for the purposes of earnings per share being net profit attributable to equity holders of the parent

4,619

6,621

14,801

Number of shares

 

 

 

Weighted average number of ordinary shares for the purposes of basic earnings per share

76,368,152

76,206,164

76,246,300

Effect of dilutive potential ordinary shares:

 

 

 

Share options

1,897,619

1,686,525

1,994,875

Weighted average number of ordinary shares for the purposes of diluted earnings per share

78,265,771

77,892,689

78,241,175

 

 6. Dividends

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Amounts recognised as distributions to equity holders in the period:

 

 

 

Final dividend for the year ended 31 December 2016 of 6.7p (2015: 6.3p) per share

5,132

4,808

4,808

Interim dividend for the year ended 31 December 2016 of 3.3p per share

-

-

2,520

Total distributions to equity holders in the period

5,132

4,808

7,328

 

The interim dividend of 3.4 pence per share has been approved by the Board and will be paid on 12 October 2017 to shareholders on the register at close of business on 15 September 2017. The interim dividend has not been included as a liability at 30 June 2017.

 

7. Share capital

During the six months ended 30 June 2017 a total of 143,679 new ordinary shares of 10 pence each were issued under the Company's share option schemes for £187,000.

 

8. Notes to the cash flow statement

 

Six months ended

Six months ended

Twelve months ended

 

30 June 2017

30 June 2016

31 December 2016

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Profit before tax

5,652

7,656

17,853

Adjustments for:

 

 

 

Share-based payments

1,625

692

969

Depreciation of property, plant and equipment

3,842

3,789

7,851

Amortisation of intangible assets

192

395

787

Research and development expenditure credit

(492)

(326)

(605)

Investment income

(112)

(281)

(449)

Foreign exchange gains

(245)

(928)

(956)

Loss/(profit) on disposal of property, plant and equipment

101

1

(3)

Increase/(decrease) in provisions

29

(1,057)

(2,759)

Operating cash flows before movements in working capital

10,592

9,941

22,688

(Increase)/decrease in inventories

(5,918)

2,000

2,841

Increase in receivables

(1,149)

(365)

(8,910)

Decrease in payables

(741)

(155)

(2,381)

Cash generated by operations

2,784

11,421

14,238

Income taxes (paid)/refunded

(3,029)

713

(303)

Net cash from operating activities

(245)

12,134

13,935

 

9. Date of approval of interim financial statements

The interim financial statements cover the period 1 January 2017 to 30 June 2017 and were approved by the Board on 6 September 2017.

Further copies of the interim financial statements are available from the Company's registered office, 316 Science Park, Cambridge CB4 0XR, and can be accessed on the Xaar plc website, www.xaar.com.

 

INTERIM REVIEW REPORT TO XAAR PLC

For the six months ended 30 June 2017

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2017 which comprises the condensed consolidated income statement, condensed consolidated statement of comprehensive income, condensed consolidated statement of financial position, condensed consolidated statement of changes in equity, condensed consolidated cash flow statement and related notes 1 to 9. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

This report is made solely to the Company in accordance with International Standard on Review Engagements (UK and Ireland) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board. Our work has been undertaken so that we might state to the Company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.

 

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the Directors. The Directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

As disclosed in note 1, the annual financial statements of the Group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union.

 

Our responsibility

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2017 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

 

Deloitte LLP

Statutory Auditor

Cambridge, United Kingdom

6 September 2017

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UGUQWBUPMGWQ
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


2017 Interim Results - RNS